Stenting Trial . It had been presented in summary type at the International Stroke Meeting in San Antonio, Texas, Feb. 26. Stroke, the third-leading reason behind death in the country, is caused by an interruption in blood circulation to the mind by a bleeding or clot. The carotid arteries on each aspect of the neck are the major source of blood flow to the brain. The buildup of cholesterol in the wall structure of the carotid artery, called atherosclerotic plaque, is normally one cause of stroke. CREST compares endarteroctomy, a medical procedure to clear blocked blood flow and prevent stroke, with carotid stenting, a newer procedure which involves threading a stent and growing a small protective gadget in the artery to widen the blocked area and catch dislodged plaque.Total operating expenses were $13.8 million in the first six months of fiscal 2010, in comparison to $12.8 million in the comparable fiscal 2009 period. Furthermore, cash found in operations was $11.2 million in the first six months of fiscal 2010 and $11.2 million in the first half a year of fiscal 2009. We continue to make excellent improvement with this Zenvia clinical development plan in PBA and so are very excited that we have filed our Complete Response with the FDA, said Keith Katkin, AVANIR’s President and CEO.